(Q40396253)

20 September 2017

title

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine (English)

1 reference

20 September 2017

0 references

Ghendon YZ

1

1 reference

20 September 2017

Markushin SG

2

1 reference

20 September 2017

Akopova II

3

1 reference

20 September 2017

Koptiaeva IB

4

1 reference

20 September 2017

Nechaeva EA

5

1 reference

20 September 2017

Mazurkova LA

6

1 reference

20 September 2017

Radaeva IF

7

1 reference

20 September 2017

Kolokoltseva TD

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

23

1 reference

20 September 2017

issue

38

1 reference

20 September 2017

page(s)

4678-4684

1 reference

Influenza vaccines: a main problem in control of pandemics

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Lessons from the influenza vaccine recall of 1996-1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Yellow fever vaccination, avian leukosis virus, and cancer risk in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Evidence for host-cell selection of influenza virus antigenic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Analysis of Genome Composition and Reactogenicity of Recombinants of Cold-adapted and Virulent Virus Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.039

10.1016/J.VACCINE.2005.04.039

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference